4.5 Article

Feasibility and Pilot Efficacy Results From the Multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) Randomized Controlled Trial

期刊

JOURNAL OF CLINICAL PSYCHIATRY
卷 73, 期 7, 页码 1016-1022

出版社

PHYSICIANS POSTGRADUATE PRESS
DOI: 10.4088/JCP.11m07100

关键词

-

资金

  1. Department of Veterans Affairs
  2. GlaxoSmithKline
  3. NIMH
  4. Novartis
  5. PsychoGenics
  6. Research Foundation for Mental Hygiene
  7. Singapore Medical Research Council
  8. Allon
  9. AstraZeneca
  10. Janssen
  11. Pfizer
  12. Sepracor
  13. Organon
  14. Abbott
  15. Bristol-Myers Squibb
  16. Eli Lilly
  17. National Institute of Mental Health [N01 MH900001]

向作者/读者索取更多资源

Background: The true benefit of pharmacologic intervention to improve cognition in schizophrenia may not be evident without regular cognitive enrichment. Clinical trials assessing the neurocognitive effects of new medications may require engagement in cognitive remediation exercises to stimulate the benefit potential. However, the feasibility of large-scale multisite studies using cognitive remediation at clinical trials sites has not been established. Method: 53 adult patients with DSM-IV schizophrenia from 9 university-affiliated sites were randomized to a cognitive remediation condition that included the Posit Science Brain Fitness auditory training program with weekly Neuropsychological and Educational Approach to Remediation (NEAR) bridging groups or a control condition of computer games and weekly healthy lifestyles groups. Patients were expected to complete 3 to 5 one-hour sessions weekly for 40 sessions or 12 weeks, whichever came first. The primary outcomes were feasibility results as measured by rate of enrollment, retention, and completion rate of primary outcome measures. The study was conducted from July 2009 through January 2010. Results: During a 3-month enrollment period, 53 (of a projected 54) patients were enrolled, and 41 (77%) met criteria for study completion. Thirty-one patients completed all 40 sessions, and all patients completed all primary outcome measures. Preliminary efficacy results indicated that, after 20 sessions, patients in the cognitive remediation condition demonstrated mean MATRICS Consensus Cognitive Battery composite score improvements that were 3.7(95% CI, 0.05-7.34) T-score points greater than in patients in the computer-games control group (F-1,F-46=4.16, P=.047). At the end of treatment, a trend favoring cognitive remediation was not statistically significant (F-1,F-47=2.26, P=.14). Conclusion: Multisite clinical trials of cognitive remediation using the Posit Science Brain Fitness auditory training program with the NEAR method of weekly bridging groups at traditional clinical sites appear to be feasible.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据